Nasdaq · CIK 0001124105
GYRE GYRE THERAPEUTICS, INC.
Insider trading from SEC Form 4. Last filing Jun 30, 2026. Close $7.04 on Oct 9, 2026, +27% from the 52-week low and -21% from the high.
GYRE THERAPEUTICS, INC. (GYRE) has 73 SEC Form 4 filings on file from 10 insiders, the latest filed on Jun 30, 2026. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
47 open-market trades have been scored at GYRE. The newest: Weiguo Ye (Chief Operating Officer) sold $69k of stock on Jun 9, 2026, filed Jun 22, 2026, scored 13 (weak). The largest of the 47 shown: Weiguo Ye (Chief Operating Officer) sold $219k on Jun 4, 2026, scored 17 (weak). 2 insiders sold within 14 days of each other around May 18, 2026.
GYRE closed at $7.04 on Oct 9, 2026, 27% above its 52-week low and 21% below its 52-week high.
1 Form 144 notice of planned sales is on file, the latest filed Nov 13, 2025.
Last 90 days
Price and insider trades, last year
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at GYRE THERAPEUTICS, INC., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 13Weak | Weiguo Ye Chief Operating Officer sell | $69k 11,000 shares | -2% | +10% from low-32% from high | |
| 5Weak | Weiguo Ye Chief Operating Officer sell | $17k 2,800 shares | -0% | +9% from low-32% from high | |
| 16Weak | Weiguo Ye Chief Operating Officer sell | $129k 20,918 shares | -3% | +10% from low-32% from high | |
| 17Weak | Weiguo Ye Chief Operating Officer sell | $219k 34,976 shares | -5% | +11% from low-31% from high | |
| 11Weak | Weiguo Ye Chief Operating Officer sell | $46k 7,500 shares | -1% | +0% from low-46% from high | |
| 16Weak | Weiguo Ye Chief Operating Officer sell | $137k 22,220 shares | -3% | 0% from low-47% from high | |
| 20Weak | Weiguo Ye Chief Operating Officer sell | $59k 9,320 shares | -1% | 0% from low-44% from high | |
| 25Weak | Weiguo Ye Chief Operating Officer sell | $195k 28,680 shares | -4% | +5% from low-39% from high | |
| 22Weak | Ying Luo Chief Executive Officer sell | $83k 10,315 shares | -0% | +17% from low-32% from high | |
| 5Weak | Songjiang Ma President sell | $26k 2,558 shares | -0% | +59% from low-39% from high | |
| 0Weak | Songjiang Ma President sell | $24k 2,182 shares | -0% | +75% from low-33% from high | |
| 6Weak | Songjiang Ma President sell | $44k 4,000 shares | -0% | +78% from low-32% from high | |
| 6Weak | Songjiang Ma President sell | $45k 4,000 shares | -0% | +77% from low-32% from high | |
| 0Weak | Songjiang Ma President sell | $22k 2,020 shares | -0% | +62% from low-38% from high | |
| 6Weak | Songjiang Ma President sell | $44k 4,000 shares | -0% | +69% from low-36% from high | |
| 0Weak | Songjiang Ma President sell | $1,740 174 shares | -0% | - | |
| 6Weak | Songjiang Ma President sell | $40k 4,000 shares | -0% | - | |
| 5Weak | Songjiang Ma President sell | $27k 2,242 shares | -0% | - | |
| 7Weak | Songjiang Ma President sell | $48k 4,000 shares | -0% | - | |
| 6Weak | Songjiang Ma President sell | $46k 4,000 shares | -0% | - | |
| 6Weak | Songjiang Ma President sell | $41k 4,000 shares | -0% | - | |
| 6Weak | Songjiang Ma President sell | $44k 4,000 shares | -0% | - | |
| 6Weak | Songjiang Ma President sell | $44k 4,000 shares | -0% | - | |
| 6Weak | Songjiang Ma President sell | $45k 4,000 shares | -0% | - | |
| 6Weak | Songjiang Ma President sell | $46k 4,000 shares | -0% | - | |
| 6Weak | Songjiang Ma President sell | $45k 4,000 shares | -0% | - | |
| 7Weak | Songjiang Ma President sell | $49k 4,000 shares | -0% | - | |
| 7Weak | Songjiang Ma President sell | $49k 4,000 shares | -0% | - | |
| 6Weak | Songjiang Ma President sell | $46k 4,000 shares | -0% | - | |
| 6Weak | Songjiang Ma President sell | $45k 3,878 shares | -0% | - | |
| 7Weak | Songjiang Ma President sell | $50k 4,000 shares | -0% | - | |
| 7Weak | Songjiang Ma President sell | $48k 4,000 shares | -0% | - | |
| 6Weak | Songjiang Ma President sell | $46k 4,000 shares | -0% | - | |
| 6Weak | Songjiang Ma President sell | $46k 4,000 shares | -0% | - | |
| 6Weak | Songjiang Ma President sell | $45k 4,000 shares | -0% | - | |
| 6Weak | Songjiang Ma President sell | $43k 4,000 shares | -0% | - | |
| 6Weak | Songjiang Ma President sell | $43k 4,000 shares | -0% | - | |
| 6Weak | Songjiang Ma President sell | $43k 4,000 shares | -0% | - | |
| 6Weak | Songjiang Ma President sell | $42k 4,000 shares | -0% | - | |
| 0Weak | Songjiang Ma President sell | $11k 1,113 shares | -0% | - | |
| 0Weak | Songjiang Ma President sell | $22k 2,216 shares | -0% | - | |
| 7Weak | Songjiang Ma President sell | $48k 4,000 shares | -0% | - | |
| 7Weak | Songjiang Ma President sell | $50k 4,000 shares | -0% | - | |
| 7Weak | Songjiang Ma President sell | $51k 4,000 shares | -0% | - | |
| 7Weak | Songjiang Ma President sell | $48k 4,000 shares | -0% | - | |
| 6Weak | Songjiang Ma President sell | $43k 4,000 shares | -0% | - | |
| 6Weak | Songjiang Ma President sell | $45k 4,000 shares | -0% | - |
Planned sales
Form 144 notices filed before a sale of restricted or control stock, newest first. The sale itself usually reaches a Form 4 within days. All planned sales
| Filed | Seller | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Nov 13, 2025 | Ye Weiguo Officer | 548,000 0.57% of outstanding | $4.6M | Nov 15, 2025 | none |
Transactions
The newest 50 of 175 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 10, 2026 | Dan Weng director | AGrant or award Stock Option (Right to Buy)derivative | +40,000 | $0.00 | $0 | 40,000 | Jun 30, 2026 |
| Jun 10, 2026 | David M. Epstein director | AGrant or award Stock Option (Right to Buy)derivative | +40,000 | $0.00 | $0 | 40,000 | Jun 30, 2026 |
| Jun 10, 2026 | Rodney L Nussbaum director | AGrant or award Stock Option (Right to Buy)derivative | +40,000 | $0.00 | $0 | 40,000 | Jun 30, 2026 |
| Jun 10, 2026 | Ping Zhang director | AGrant or award Stock Option (Right to Buy)derivative | +40,000 | $0.00 | $0 | 40,000 | Jun 30, 2026 |
| Jun 10, 2026 | Renate Parry director | AGrant or award Stock Option (Right to Buy)derivative | +40,000 | $0.00 | $0 | 40,000 | Jun 30, 2026 |
| Jun 10, 2026 | Gordon Carmichael director | AGrant or award Stock Option (Right to Buy)derivative | +40,000 | $0.00 | $0 | 40,000 | Jun 30, 2026 |
| Jun 9, 2026 | Weiguo Ye Chief Operating Officer | MOption exercise Common Stock | +3,000 | $0.75 | $2,250 | 703,000 | Jun 22, 2026 |
| Jun 9, 2026 | Weiguo Ye Chief Operating Officer | SOpen-market sale Common Stock | -3,000 | $6.15 | $18k | 700,000 | Jun 22, 2026 |
| Jun 10, 2026 | Weiguo Ye Chief Operating Officer | MOption exercise Common Stock | +5,000 | $0.75 | $3,750 | 705,000 | Jun 22, 2026 |
| Jun 10, 2026 | Weiguo Ye Chief Operating Officer | SOpen-market sale Common Stock | -5,000 | $6.24 | $31k | 700,000 | Jun 22, 2026 |
| Jun 18, 2026 | Weiguo Ye Chief Operating Officer | MOption exercise Common Stock | +3,000 | $0.75 | $2,250 | 703,000 | Jun 22, 2026 |
| Jun 18, 2026 | Weiguo Ye Chief Operating Officer | SOpen-market sale Common Stock | -3,000 | $6.35 | $19k | 700,000 | Jun 22, 2026 |
| Jun 9, 2026 | Weiguo Ye Chief Operating Officer | MOption exercise Stock Option (Right to Buy)derivative | -3,000 | $0.00 | $0 | 835,701 | Jun 22, 2026 |
| Jun 10, 2026 | Weiguo Ye Chief Operating Officer | MOption exercise Stock Option (Right to Buy)derivative | -5,000 | $0.00 | $0 | 830,701 | Jun 22, 2026 |
| Jun 18, 2026 | Weiguo Ye Chief Operating Officer | MOption exercise Stock Option (Right to Buy)derivative | -3,000 | $0.00 | $0 | 827,701 | Jun 22, 2026 |
| Jun 11, 2026 | Weiguo Ye Chief Operating Officer | MOption exercise Common Stock | +2,800 | $0.75 | $2,100 | 702,800 | Jun 15, 2026 |
| Jun 11, 2026 | Weiguo Ye Chief Operating Officer | SOpen-market sale Common Stock | -2,800 | $6.17 | $17k | 700,000 | Jun 15, 2026 |
| Jun 11, 2026 | Weiguo Ye Chief Operating Officer | MOption exercise Stock Option (Right to Buy)derivative | -2,800 | $0.00 | $0 | 838,701 | Jun 15, 2026 |
| Jun 9, 2026 | Weiguo Ye Chief Operating Officer | MOption exercise Common Stock | +14,500 | $0.75 | $11k | 714,500 | Jun 11, 2026 |
| Jun 9, 2026 | Weiguo Ye Chief Operating Officer | SOpen-market sale Common Stock | -14,500 | $6.14 | $89k | 700,000 | Jun 11, 2026 |
| Jun 10, 2026 | Weiguo Ye Chief Operating Officer | MOption exercise Common Stock | +6,418 | $0.75 | $4,814 | 706,418 | Jun 11, 2026 |
| Jun 10, 2026 | Weiguo Ye Chief Operating Officer | SOpen-market sale Common Stock | -6,418 | $6.21 | $40k | 700,000 | Jun 11, 2026 |
| Jun 9, 2026 | Weiguo Ye Chief Operating Officer | MOption exercise Stock Option (Right to Buy)derivative | -14,500 | $0.00 | $0 | 847,919 | Jun 11, 2026 |
| Jun 10, 2026 | Weiguo Ye Chief Operating Officer | MOption exercise Stock Option (Right to Buy)derivative | -6,418 | $0.00 | $0 | 841,501 | Jun 11, 2026 |
| Jun 8, 2026 | Joshua Benjamin Bergmann GC and Corporate Secretary | AGrant or award Stock Option (Right to Buy)derivative | +50,000 | $0.00 | $0 | 50,000 | Jun 10, 2026 |
| Jun 8, 2026 | Ying Luo Chief Executive Officer | AGrant or award Stock Option (Right to Buy)derivative | +120,000 | $0.00 | $0 | 120,000 | Jun 10, 2026 |
| Jun 4, 2026 | Weiguo Ye Chief Operating Officer | MOption exercise Common Stock | +19,575 | $0.75 | $15k | 719,575 | Jun 8, 2026 |
| Jun 4, 2026 | Weiguo Ye Chief Operating Officer | SOpen-market sale Common Stock | -19,575 | $6.13 | $120k | 700,000 | Jun 8, 2026 |
| Jun 5, 2026 | Weiguo Ye Chief Operating Officer | MOption exercise Common Stock | +15,401 | $0.75 | $12k | 715,401 | Jun 8, 2026 |
| Jun 5, 2026 | Weiguo Ye Chief Operating Officer | SOpen-market sale Common Stock | -15,401 | $6.40 | $99k | 700,000 | Jun 8, 2026 |
| Jun 4, 2026 | Weiguo Ye Chief Operating Officer | MOption exercise Stock Option (Right to Buy)derivative | -19,575 | $0.00 | $0 | 877,820 | Jun 8, 2026 |
| Jun 5, 2026 | Weiguo Ye Chief Operating Officer | MOption exercise Stock Option (Right to Buy)derivative | -15,401 | $0.00 | $0 | 862,419 | Jun 8, 2026 |
| May 22, 2026 | Weiguo Ye Chief Operating Officer | MOption exercise Common Stock | +3,500 | $0.75 | $2,625 | 703,500 | May 27, 2026 |
| May 22, 2026 | Weiguo Ye Chief Operating Officer | SOpen-market sale Common Stock | -3,500 | $6.08 | $21k | 700,000 | May 27, 2026 |
| May 26, 2026 | Weiguo Ye Chief Operating Officer | MOption exercise Common Stock | +4,000 | $0.75 | $3,000 | 704,000 | May 27, 2026 |
| May 26, 2026 | Weiguo Ye Chief Operating Officer | SOpen-market sale Common Stock | -4,000 | $6.10 | $24k | 700,000 | May 27, 2026 |
| May 22, 2026 | Weiguo Ye Chief Operating Officer | MOption exercise Stock Option (Right to Buy)derivative | -3,500 | $0.00 | $0 | 901,395 | May 27, 2026 |
| May 26, 2026 | Weiguo Ye Chief Operating Officer | MOption exercise Stock Option (Right to Buy)derivative | -4,000 | $0.00 | $0 | 897,395 | May 27, 2026 |
| May 20, 2026 | Weiguo Ye Chief Operating Officer | MOption exercise Common Stock | +9,400 | $0.75 | $7,050 | 709,400 | May 22, 2026 |
| May 20, 2026 | Weiguo Ye Chief Operating Officer | SOpen-market sale Common Stock | -9,400 | $6.15 | $58k | 700,000 | May 22, 2026 |
| May 21, 2026 | Weiguo Ye Chief Operating Officer | MOption exercise Common Stock | +12,820 | $0.75 | $9,615 | 712,820 | May 22, 2026 |
| May 21, 2026 | Weiguo Ye Chief Operating Officer | SOpen-market sale Common Stock | -12,820 | $6.15 | $79k | 700,000 | May 22, 2026 |
| May 20, 2026 | Weiguo Ye Chief Operating Officer | MOption exercise Stock Option (Right to Buy)derivative | -9,400 | $0.00 | $0 | 917,715 | May 22, 2026 |
| May 21, 2026 | Weiguo Ye Chief Operating Officer | MOption exercise Stock Option (Right to Buy)derivative | -12,820 | $0.00 | $0 | 904,895 | May 22, 2026 |
| May 14, 2026 | Ping Zhang director | DDisposition to issuer Stock Option (Right to Buy)derivative | -250,000 | $0.00 | $0 | 0 | May 20, 2026 |
| May 18, 2026 | Weiguo Ye Chief Operating Officer | MOption exercise Common Stock | +200 | $0.75 | $150 | 700,200 | May 20, 2026 |
| May 18, 2026 | Weiguo Ye Chief Operating Officer | SOpen-market sale Common Stock | -200 | $6.62 | $1,324 | 700,000 | May 20, 2026 |
| May 19, 2026 | Weiguo Ye Chief Operating Officer | MOption exercise Common Stock | +9,120 | $0.75 | $6,840 | 709,120 | May 20, 2026 |
| May 19, 2026 | Weiguo Ye Chief Operating Officer | SOpen-market sale Common Stock | -9,120 | $6.37 | $58k | 700,000 | May 20, 2026 |
| May 18, 2026 | Weiguo Ye Chief Operating Officer | MOption exercise Stock Option (Right to Buy)derivative | -200 | $0.00 | $0 | 936,235 | May 20, 2026 |
Insiders
Everyone who has filed a Form 4 here.
- Joshua Benjamin BergmannGC and Corporate Secretary
- Gordon Carmichaeldirector
- David M. Epsteindirector
- Ying LuoChief Executive Officer
- Songjiang MaPresident
- Rodney L Nussbaumdirector
- Renate Parrydirector
- Dan Wengdirector
- Weiguo YeChief Operating Officer
- Ping Zhangdirector
Questions about GYRE
Answered from the filings on this page, as of the latest one.
Are insiders buying GYRE?
No. In the last 90 days no insider at GYRE THERAPEUTICS, INC. bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade GYRE on the open market?
Weiguo Ye (Chief Operating Officer) sold $69k of GYRE on Jun 9, 2026 and filed the Form 4 on Jun 22, 2026. InsiderTell scored 13 (weak).
How many insiders file Form 4 at GYRE THERAPEUTICS, INC.?
10 people have filed a Form 4 at GYRE THERAPEUTICS, INC., among them Joshua Benjamin Bergmann (GC and Corporate Secretary), Gordon Carmichael (director), David M. Epstein (director). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.